BAILARD, INC. - CASI PHARMACEUTICALS INC ownership

CASI PHARMACEUTICALS INC's ticker is CASI and the CUSIP is 14757U109. A total of 46 filers reported holding CASI PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BAILARD, INC. ownership history of CASI PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$20,000
-68.3%
25,100
-37.9%
0.00%
-50.0%
Q2 2021$63,00040,4000.00%
Other shareholders
CASI PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Wellington Shields & Co., LLC 518,583$928,0000.58%
Wellington Shields Capital Management, LLC 851,705$1,525,0000.25%
SABBY MANAGEMENT, LLC 788,485$1,411,0000.05%
Moors & Cabot, Inc. 95,696$175,0000.03%
Geduld E E 20,000$36,0000.02%
Manatuck Hill Partners, LLC 15,090$27,0000.01%
EVERETT HARRIS & CO /CA/ 10,002$18,0000.00%
CITIGROUP INC 11,499$21,0000.00%
UBS AG 2,054$4,0000.00%
GEODE CAPITAL MANAGEMENT, LLC 38,700$69,0000.00%
View complete list of CASI PHARMACEUTICALS INC shareholders